Two-Photon-Excited Fluorescence of Benzothiazole-Based Compounds
0.025 mol) and a small amount of benzoyl peroxide were added crystallography, were obtained by recrystallization from chloro-
FULL PAPER
together. The mixture was heated under reflux for 8 h. After cool-
ing to room temperature, the precipitate was filtered off and the
filtrate was purified by column chromatography on silica gel using
chloroform/petroleum ether (1:9) as eluent. A colorless powder was
obtained (2.9 g, 35%). 1H NMR (CDCl3): δ ϭ 4.50 (s, 2 H),
7.21Ϫ7.62 (m, 8 H), 7.76Ϫ8.06 (m, 2 H) ppm.
form. M.p. 296Ϫ297 °C. 1H NMR (600 MHz, CDCl3): δ ϭ 7.26
(d, J(E) ϭ 16.6 Hz, 1 H), 7.31Ϫ7.33 (m, 3 H), 7.41Ϫ7.51 (m, 7 H),
7.59 (d, J(E) ϭ 16.7 Hz, 1 H), 7.61Ϫ7.64 (m, 6 H), 7.78 (d, J ϭ
8.3 Hz, 2 H), 7.90 (d, J ϭ 7.8 Hz, 1 H), 8.04 (d, J ϭ 8.0 Hz, 1 H),
8.17 (d, J ϭ 7.8 Hz, 2 H) ppm. MS: m/z (%) ϭ 504 (100) [Mϩ],
252 (51) [M]2ϩ. UV/Vis (THF): λmax (ε) ϭ 384 nm (7.4·104). IR
(KBr): ν˜ ϭ 1593 (m), 1513 (s), 1477 (m), 1450 (s), 1334 (m), 1312
(m), 1231 (s), 1169 (w), 1103 (m), 955 (s), 824 (m), 750 (s), 724 (s)
cmϪ1. C35H24N2S (504.7): calcd. C 83.30, H 4.79, N 5.55, S 6.35;
found C 83.04, H 4.81, N 5.50, S 6.31.
{4-[2-(1,3-Benzothiazole-2-yl)ethenyl]benzyl}triphenylphosphonium
Bromide (7Ј): A mixture of 6Ј (4.0 g, 0.012 mol) and triphenylphos-
phane (3.2 g, 0.012 mol) in freshly distilled toluene (200 mL) was
heated under reflux for 5 h. The mixture was then placed in a re-
frigerator overnight and then the crude precipitate was filtered off
and washed with ethanol. A yellow powder (5.7 g, 80%) was ob-
tained and used directly in the next step without further purifi-
cation.
trans,trans-2-{4-[2-(Thiophen-2-yl)ethenyl]styryl}-1,3-benzothiazole
(4, TESB): By reaction of 4Ј and 7Ј, a yellow-green powder (0.53 g,
38%) was obtained. M.p. 240Ϫ241 °C, 1H NMR (600 MHz,
CDCl3): δ ϭ 6.95 (d, J(E) ϭ 16.1 Hz, 1 H), 7.04 (m, 1 H), 7.13 (d,
J ϭ 3.3 Hz, 1 H), 7.25 (d, J ϭ 5.0 Hz, 1 H), 7.32 (d, J(E) ϭ 16.0 Hz,
1 H), 7.40 (t, J ϭ 7.3 Hz, 1 H), 7.44 (d, J(E) ϭ 16.1 Hz, 1 H),
7.49Ϫ7.60 (m, 6 H), 7.89 (d, J ϭ 7.9 Hz, 1 H), 8.03 (d, J ϭ 8.1 Hz,
1 H) ppm. MS: m/z (%) ϭ 344 (100) [Mϩ]. UV/Vis (THF): λmax
(ε) ϭ 380 nm (4.4·104). IR (KBr): ν˜ ϭ 1619 (m), 1591 (m), 1477
(m), 1431 (m), 1412 (m), 1312 (m), 1231 (m), 1192 (m), 956 (s), 864
(m), 821 (s), 754 (s), 728 (s), 697 (s), 666 (m) cmϪ1. C21H15NS2
(345.5): calcd. C 73.01, H 4.38, N 4.05, S 18.56; found C 72.69, H
4.29, N 4.13, S 18.44.
trans,trans-2-{4-[4-(N,N-Diethylamino)styryl]styryl}-1,3-
benzothiazole (1, DESSB): A mixture of 7Ј (2.5 g, 0.004 mol) and
1Ј (0.71 g, 0.004 mol) was suspended in freshly distilled THF
(40 mL) and then potassium tert-butoxide (0.7 g, 0.006 mol) in tert-
butyl alcohol (60 mL) was added dropwise under nitrogen with stir-
ring in an ice-bath. The mixture was continuously stirred at room
temperature for further 20 h. The mixture was poured into a beaker
containing distilled water (200 mL) and the pH value of the mix-
ture was adjusted to 7.0 by addition of dilute hydrochloric acid.
This mixture was extracted with dichloromethane, the organic
phases were washed twice with distilled water, and then the organic
solvent was removed using a rotary evaporator. To isomerize the
crude material to the trans-configured object compound, the resi-
due was dissolved in toluene (ca. 50 mL) containing a trace amount
of iodine and then the mixture was heated under reflux for further
4 h. The solvent was evaporated, the residue was purified by col-
umn chromatography on silica gel using chloroform/petroleum
ether (1:1) as eluent, and the product was then recrystallized from
chloroform to yield a red powder (0.66 g, 40%). M.p. 227Ϫ230 °C,
1H NMR (600 MHz, CDCl3): δ ϭ 1.21 (t, J ϭ 7.0 Hz, 6 H), 3.41
X-ray Crystallographic Study of 3 (CSSB): X-Ray diffraction data
of a yellow-green single crystal of 3 (0.45 ϫ 0.42 ϫ 0.08 mm) were
collected on a Bruker P4 four-circle diffractometer using Mo-Kα
radiation. Of 5781 collected reflections (4.04 Յ 2θ Յ 49.98), 4569
reflections were independent (Rint ϭ 0.0340). The structure was
resolved using the SHELXTL-97 program by a direct method and
refined by a full-matrix least-squares method on F2. The crystal
belongs to the monoclinic system, P21/c space group, with formula
C35H24N2S and molecular weight 504.62; T ϭ 293(2) K, a ϭ
˚
8.0149(9), b ϭ 40.378(4), c ϭ 8.0607(12) A, β ϭ 97.480(10)°, V ϭ
3
2586.4(5) A , Z ϭ 4, dcalcd. ϭ 1.306 Mg/m3, µ ϭ 0.153 mmϪ1
,
˚
F(000) ϭ 1072, R1 ϭ 0.1005, wR2 ϭ 0.2586 [I Ͼ 2σ(I)].
(q, J ϭ 7.0 Hz, 4 H), 6.69 (d, J ϭ 8.6 Hz, 2 H), 6.91 (d, J(E)
ϭ
16.2 Hz, 1 H), 7.13 (d, J(E) ϭ 16.2 Hz, 1 H), 7.37Ϫ7.43 (m, 4 H),
7.47Ϫ7.57 (m, 6 H), 7.88 (d, J ϭ 8.0 Hz, 1 H), 8.01 (d, J ϭ 8.1 Hz,
1 H) ppm. MS: m/z (%) ϭ 410 (100) [Mϩ], 395 (89) [M Ϫ CH3]ϩ.
UV/Vis (THF): λmax (ε) ϭ 425 nm (5.8·104). IR (KBr): ν˜ ϭ 2969
(w), 1585 (s), 1519 (s), 1478 (m), 1402(m), 1357 (m), 1266 (s), 1186
(s), 1152 (s), 961 (s), 818 (s), 757 (s), 731 (m) cmϪ1. C27H26N2S
(410.6): calcd. C 78.99, H 6.38, N 6.82, S 7.81; found C 78.68, H
6.31, N 6.65, S 7.69.
CCDC-191317 contains the supplementary crystallographic data
for this paper. These data can be obtained free of charge at
www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge
Crystallographic Data Centre, 12, Union Road, Cambridge
CB2 1EZ, UK; fax: (internat.) ϩ44Ϫ1223/336-033; E-mail:
deposit@ccdc.cam.ac.uk].
Acknowledgments
trans,trans-2-{4-[4-(N,N-Diphenylamino)styryl]styryl}-1,3-benzo-
thiazole (2, DPSSB): By reaction of 2Ј and 7Ј, DPSSB was pre-
pared as a yellow powder (0.85 g, 42%) following a method similar
to that described above. M.p. 277Ϫ278 °C. 1H NMR (600 MHz,
CDCl3): δ ϭ 7.02 (d, J(E) ϭ 16.3 Hz, 1 H), 7.05Ϫ7.08 (m, 4 H),
7.13Ϫ7.16 (m, 5 H), 7.28Ϫ7.30 (m, 4 H), 7.41Ϫ7.43 (m, 3 H), 7.45
(d, J(E) ϭ 16.1 Hz, 1 H), 7.50Ϫ7.60 (m, 6 H), 7.89 (d, J ϭ 7.9 Hz,
1 H), 8.03 (d, J ϭ 8.1 Hz, 1 H) ppm. MS: m/z (%) ϭ 506 (100)
[Mϩ], 253 (24) [M]2ϩ. UV/Vis (THF): λmax (ε) ϭ 412 nm (6.9·104).
IR (KBr): ν˜ ϭ 3026 (w), 1588 (s), 1512 (m), 1489 (s), 1331 (m),
1280 (s), 1176 (m), 1107 (w), 961 (s), 826 (m), 755 (s), 729 (m), 695
(s) cmϪ1. C35H26N2S (506.7): calcd. C 82.97, H 5.17, N 5.53, S
6.33; found C 82.39, H 5.07, N 5.31, S 6.49.
This work was supported by the National Nature Science Foun-
dation of China (No. 20172034), the Foundation for University
Key Teachers by the Ministry of Education, and by a grant from
the State Key Program of China.
[1]
J. D. Bhawalkar, G. S. He, P. N. Prasad, Rep. Prog. Phys. 1996,
59, 1041Ϫ1070.
[2]
´
M. Albota, D. Beljonne, J.-L. Bredas, J. E. Ehrlich, J.-Y. Fu,
A. A. Heikal, S. E. Hess, T. Kogej, M. D. Levin, S. R. Marder,
D. McCord-Maughon, J. W. Perry, H. Röckel, M. Rumi, G.
Subramaniam, W. W. Webb, X.-L. Wu, C. Xu, Science 1998,
281, 1653Ϫ1656.
D. A. Parthenopoulos, P. M. Rentzepis, Science 1989, 245,
843Ϫ845.
G. S. He, J. D. Bhawalkar, C. F. Zhao, P. N. Prasad, Appl. Phys.
Lett. 1995, 67, 2433Ϫ2435.
J. E. Ehrlich, X. L. Wu, I.-Y. S. Lee, Z.-Y. Hu, H. Röckel, S.
R. Marder, J. W. Perry, Opt. Lett. 1997, 22, 1843Ϫ1845.
[3]
[4]
[5]
trans,trans-2-{4-[4-(N-Carbazolyl)styryl]styryl}-1,3-benzothiazole
(3, CSSB): By reaction of 3Ј and 7Ј, yellow-green microcrystals of
3 (0.91 g, 45%) were obtained following a procedure similar to that
described above. Platelet crystals, which were suitable for X-ray
Eur. J. Org. Chem. 2003, 3628Ϫ3636
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3635